CompletedInterventionalPhase 1Last updated Jun 15, 2022

Single Blind Cross-over Dose Response Study in Subjects of Two Inhalers of Salmeterol and Fluticasone Propionate

Phase I Single Blind, Randomised, Cross-over Pharmacodynamic Dose Response Study in Healthy Volunteers of Two Pressurized Metered Dose Inhalers (pMDIs) That Deliver Salmeterol and Fluticasone Propionate

Overview

ClinicalTrials.gov ID: NCT02232087
Lead Sponsor: Kindeva Drug DeliveryINDUSTRY
Brief Summary: The purpose of this study is to test the body's response to several doses of two different inhalation products in healthy volunteers.
Study Type: Interventional

Status

Overall Status: Completed
Start Date: Jul 2014
Primary Completion Date: Oct 2014Actual
Completion Date: Dec 2014Actual

Study Record Dates

First Submitted: Sep 2, 2014
First Submitted that Met QC Criteria: Sep 2, 2014
First Posted: Sep 4, 2014Estimated
Last Update Submitted that Met QC Criteria: Jun 13, 2022
Last Update Posted: Jun 15, 2022Actual
Last Verified: Oct 2020

NCT03060044Completed

Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler and Seretide Diskus

NCT02162485Completed

Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler Products and Seretide Diskus

NCT01795664Completed

Compare the Effects of Seretide® Evohaler and a Generic Salmeterol/Fluticasone Hydrofluoroalkane (HFA) Pressurized Metered-dose Inhaler (pMDI) on Functional Respiratory Imaging Parameters in Asthmatic Patients

NCT00364442Completed

Repeat Dose Study of Fluticasone Propionate/Salmeterol Versus Fluticasone Propionate + Salmeterol In Asthmatics

NCT01856621Completed

Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler With Seretide Diskus

NCT02094274Completed

A Single-dose, Randomised, Crossover, Placebo-controlled Study Assessing Two Fixed-dose Combinations of Inhaled Long-acting Beta-agonist and Corticosteroid